Humanity & Health Clinical Trial Centre

Hong Kong

0 studies enrolling now · 2 studies all time

What they study most

Adjuvant, EGFR, Early Stage Lung Cancer, Exon 20, Hepatocellular Carcinoma, Lung Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Uncommon EGFR Mutations

Studies at this site

• A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling